Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

EQRx, Inc. - Common Stock (NQ: EQRX )

4.820 +0.100 (+2.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,220,690
Open 4.770
Bid (Size) 4.490 (1)
Ask (Size) 5.120 (16)
Prev. Close 4.720
Today's Range 4.480 - 5.030
52wk Range 2.630 - 8.700
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bumble, Hanesbrands, Sonos And Some Other Big Losers From Thursday
U.S. stocks closed mixed on Thursday following the release of PPI data. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session
Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering. 
Via Benzinga

Performance

YTD
-31.44%
-31.44%
1 Month
+5.47%
+5.47%
3 Month
+7.11%
+7.11%
6 Month
+46.95%
+46.95%
1 Year
-41.00%
-41.00%

More News

Read More
EQRx's Lung Cancer Candidate Shows Improved Progression-Free Survival Versus Placebo
Via Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
Via Benzinga
CStone's Commercialization Capacity Put to Test With Latest Drug Approval
Via Benzinga
EQRx to Hold Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022
From Eqrx, Inc.
Via Globe NewsWire
71 Biggest Movers From Yesterday
Via Benzinga
55 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
Via Benzinga
56 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
110 Biggest Movers From Friday
Via Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Via Benzinga
Earnings Scheduled For May 13, 2022
Via Benzinga
How Rivals Merck, Bristol Myers Benefit From Eli Lilly's FDA Snag
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 18, 2022
Via Benzinga
Earnings Scheduled For March 23, 2022
Via Benzinga
Cramer Gives His Opinion On ADT, Occidental Petroleum And More
Via Benzinga
48 Biggest Movers From Yesterday
Via Benzinga
75 Biggest Movers From Yesterday
Via Benzinga
FDA Clears Turning Point's IND For Elzovantinib + Aumolertinib Combo Regime In Lung Cancer Setting
Via Benzinga
46 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
78 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.